Basic Fundamentals of Drug Delivery

• Broschiertes Buch

Produktbeschreibung

Basic Fundamentals of Drug Delivery covers the fundamental principles, advanced methodologies and technologies employed by pharmaceutical scientists, researchers and pharmaceutical industries to transform a drug candidate or new chemical entity into a final administrable drug delivery system. The book also covers various approaches involved in optimizing the therapeutic performance of a biomolecule while designing its appropriate advanced formulation.

Produktdetails

• Verlag: Elsevier Health Sciences
• Seitenzahl: 810
• Erscheinungstermin: 12. Dezember 2018
• Englisch
• Abmessung: 241mm x 187mm x 43mm
• Gewicht: 1609g
• ISBN-13: 9780128179093
• ISBN-10: 0128179090
• Artikelnr.: 53930093

Inhaltsangabe

1. Scientific rationale for designing controlled drug delivery systems 2.
Current developments in excipient science: Implication of quantitative
selection of each excipient in product development 3. Fundamentals of
polymers science applied in Pharmaceutical Product Development 4. Use of
polymers in controlled release of active agents 5. Co-polymers and block
co-polymers in drug delivery and therapy 6. Pharmaceutical and biomedical
applications of polymers 7. Levels of Drug targeting 8. Ligands for
targeted drug delivery and applications 9. Transportation and bio
interaction Properties in nanomaterials across biological systems 10.
Importance of preliminary characterisation of nanoparticles in
pharmaceutical product development 11. Biodegradable Block Copolymers and
Their Applications For Drug Delivery 12. Bio-Nanotechnology in
pharmaceutical research 13. Design and evaluation of ophthalmic delivery
formulations 14. Design and fabrication of Brain targeted drug delivery 15.
Cutaneous and transdermal drug delivery: Techniques and Delivery systems
16. Protein/peptide drug delivery systems: Practical considerations in
Pharmaceutical Product Development 17. Nanocarriers in different
preclinical and clinical stages 18. Clinical aspects and regulatory
requirements for nanomedicines